Chang-Kang-Fang Ameliorates Experimental Diarrhea Predominant Irritable Bowel Syndrome by Regulating Gut Microbiota and Gut -Brain Axis

Abstract Background: Chang-Kang-Fang formula (CKF), a multi-herb traditional Chinese medicinal formula, has been clinically used for treatment of irritable bowel syndrome with diarrhea (IBS-D). Though we have reported the compounds of CKF and the therapeutic effect on IBS-D rats, the exact mechanism underlying is still not clear. The aim of this study is to clearly define the effect of CKF on IBS-D by regulating gut microbiota and gut-brain axis. Method: We investigated the effects of CKF on IBS-D rat model, established by psychosocial stress (restraint) combined with the peripheral stimulation (senna leaf gavage) stress. The changed of body weight and the number of fecal pellets was investigated during the experiment. The effect on intestinal sensitivity was assessed based on the abdominal withdrawal reflex (AWR) scores and the intestinal permeability, the expression of ZO-1, measured by immunohistochemistry. The effect of CKF on gut-brain axis was evaluated by the expression of 5-HT through immunohistochemistry. The composition of gut microbiota was detected through 16sRNA. Results: Administration of CKF significantly have shown the therapeutic effect on IBS-D rats, involving decreased the score of AWR and increased the number of pellets, though there were no different on body weight change. In addition, CKF could upregulated the expression of ZO-1 in colon and downregulated the expression of 5-HT in colon and brain Moreover, CKF could rebalance the gut microbiota of IBS-D, increasing the abundance of Lactobacillu, Allobaculum, Roseburia and Lachnospiraceae_NK4A136. Conclusion: CKF potentially alleviates IBS-D through regulating gut microbiota and gut-brain axis.

[1]  S. Sacco,et al.  Gut-brain Axis and migraine headache: a comprehensive review , 2020, The Journal of Headache and Pain.

[2]  Fei Li,et al.  Effect of water extract from Berberis heteropoda Schrenk roots on diarrhea-predominant irritable bowel syndrome by adjusting intestinal flora. , 2019, Journal of ethnopharmacology.

[3]  Ying Xu,et al.  Resveratrol Improves Brain-Gut Axis by Regulation of 5-HT-Dependent Signaling in the Rat Model of Irritable Bowel Syndrome , 2019, Front. Cell. Neurosci..

[4]  B. Lacy,et al.  Management of irritable bowel syndrome with diarrhea: a review of nonpharmacological and pharmacological interventions , 2019, Therapeutic advances in gastroenterology.

[5]  Morris A. Swertz,et al.  Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome , 2018, Science Translational Medicine.

[6]  Harry Sokol,et al.  Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease. , 2018, Cell host & microbe.

[7]  Xia Li,et al.  Chemical profiles and pharmacological activities of Chang-Kang-Fang, a multi-herb Chinese medicinal formula, for treating irritable bowel syndrome. , 2017, Journal of ethnopharmacology.

[8]  Tao-Tao Liu,et al.  Altered molecular signature of intestinal microbiota in irritable bowel syndrome patients compared with healthy controls: A systematic review and meta-analysis. , 2017, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[9]  J. Sonnenburg,et al.  Gut microbes promote colonic serotonin production through an effect of short‐chain fatty acids on enterochromaffin cells , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  Paul J Kennedy,et al.  Irritable bowel syndrome: a microbiome-gut-brain axis disorder? , 2014, World journal of gastroenterology.

[11]  W. Chung,et al.  Effect of multispecies probiotics on irritable bowel syndrome: A randomized, double‐blind, placebo‐controlled trial , 2014, Journal of gastroenterology and hepatology.

[12]  M. Bellini,et al.  Serotonin receptors and their role in the pathophysiology and therapy of irritable bowel syndrome , 2014, Techniques in Coloproctology.

[13]  Jerrold R. Turner,et al.  Intestinal mucosal barrier function in health and disease , 2009, Nature Reviews Immunology.

[14]  S. Ahrné,et al.  Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome , 2000, American Journal of Gastroenterology.

[15]  G. Sturniolo,et al.  [Irritable bowel syndrome]. , 1988, Giornale di clinica medica.